At the news
? BEARISHIMPACT 5/10 8-K/A filed Nov 12, 2026 at 16:09 ET
Neuronetics filed an 8-K/A solely to re-file Exhibit 5.1 (legal opinion) and Exhibit 23.1 (consent) for a previously disclosed underwritten public offering of 18,750,000 shares at $1.60 per share, with an underwriter option for an additional 2,812,500 shares. The amendment does not change any substantive terms of the offering; net proceeds are estimated at $27.7 million (or $31.9 million if the option is fully exercised), to be used partly to repay debt under the Perceptive Facility and for general corporate purposes.
- Company entered into underwriting agreement to sell 18,750,000 shares of common stock at $1.60 per share to the public.
- Underwriters have a 30-day option to purchase an additional 2,812,500 shares on the same terms.
- Estimated net proceeds of approximately $27.7 million (or $31.9 million if the option is exercised in full).
- Proceeds will be used to repay a portion of the outstanding $65 million term loan under the Perceptive Facility (11.5% interest rate, matures July 2029) and for general corporate purposes.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access